Real-life Comparison of Mortality in Patients with SARS-CoV-2 Infection at Risk for Clinical Progression Treated with Molnupiravir or Nirmatrelvir Plus Ritonavir During the Omicron Era in Italy: a Nationwide, Cohort Study.
The Lancet Regional Health - Europe（2023）
关键词
COVID-19,SARS-CoV-2,Nirmatrelvir/ritonavir,Molnupiravir,Real-world,Effectiveness
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要